RecruitingNot ApplicableNCT04876742

Wheat Beer for Prevention of Delirium in Intensive Care Patients

A Randomised Placebo-controlled Double-blind Exploratory Trial Within Cohort Using Wheat Beer for Prevention of Delirium in Intensive Care Patients

Sponsor

University Hospital, Basel, Switzerland

Enrollment

380 participants

Start Date

Jan 18, 2023

Study Type

INTERVENTIONAL

Conditions

ICU delirium

Summary

The investigators hypothesise that the daily administration of 0.5L alcohol-containing wheat beer at 8 pm over a study period of 6 days in a row leads to a lower prevalence of delirium compared to water following the same administration scheme.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Beer and Water for people with icu delirium. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERBeer

As interventive agent 0.5 L organic alcohol-containing wheat beer produced by the brewery "Unser Bier" in Basel, Switzerland, is administered once a day at 8pm for 6 consecutive days after enrolment.

OTHERWater

For the interventional control group 0.5L water is administered once a day at 8pm for 6 consecutive days after enrolment.

Locations(1)

University Hospital Basel

Basel, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04876742

Related Trials